Send the following on WhatsApp
Continue to ChatNovavax 提交申請,在歐盟將 2019 冠狀病毒病疫苗的有條件上市授權擴大至青少年(12-17 歲) https://geneonline.news/nuvaxovid-novavax-covid/
Novavax 提交申請,在歐盟將 2019 冠狀病毒病疫苗的有條件上市授權擴大至青少年(12-17 歲) https://geneonline.news/nuvaxovid-novavax-covid/